The Latest Breaking News from Nasdaq

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

TriMas Corp (NASDAQ:TRS) has secured multi-year contracts from Boeing Co (NYSE:BA). The financial terms were not disclosed. TriMas Aerospace's RSA Engineered Products (RSA) business was awarded several components used in fluid conveyance applications, more specifically within the air ducting system, by Boeing for its T-7A Red Hawk training jet program. "We are proud…

Meta Platforms Inc (NASDAQ: FB) was trading more than 2% higher on Wednesday, breaking up from a triple inside bar on the daily chart.

The financial analyst day, product sessions, and customer discussions at MongoDB, Inc (NASDAQ:MDB) World in New York increased confidence in Piper Sandler analyst Brent A. Bracelin. Bracelin found MDB well-positioned for further share gains within the $78 billion+ database management systems market.  The combination of new product enhancements, including Atlas Serverless, Relational Migrator tool, and…

A Bank of America analyst remains bearish on Novavax, Inc (NASDAQ: NVAX) after a regulatory panel approved Novavax’s Emergency Use Authorization request fo

Capstone Green Energy Corp (NASDAQ:CGRN) distributor for the Mid-Atlantic and Southeastern U.S. and the Caribbean, E-Finity Distributed Generation, secured two new 36-month Energy-as-a-Service (EaaS) contracts from a cryptocurrency mining company. Financial terms were not disclosed. Capstone said it focuses on growing the EaaS business model as it provides higher margins and more constant…

Baidu, Inc (NASDAQ:BIDU) electric vehicle arm Jidu Auto launched a "robot" concept car via an online press conference held on Baidu's metaverse-themed app Xirang. It is the first vehicle to be revealed by a Chinese internet company. The concept car is free of door handles and is fully controlled via voice recognition, Reuters reports.…

Within the last quarter, Bed Bath & Beyond (NASDAQ:BBBY) has observed the following analyst ratings:

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced updated data from a Phase 1 clinical trial of galinpepimut-S (GPS), combined with Bristol-Myers Squibb Co's (NYSE:BMY) nivolumab (Opdivo) in with malignant pleural mesothelioma (MPM). The trial included patients who were either refractory or relapsed after at least one line of the standard of care therapy. Data from…

Someone with a lot of money to spend has taken a bearish stance on Palo Alto Networks (NASDAQ:PANW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Tiziana Life Sciences (NASDAQ: TLSA) reported clinical results from the second patient with Secondary Progressive Multiple Sclerosis (SPMS) in the ongoing study as part of an expanded access program.